Paper
29 December 1997 Photodynamic therapy of head and neck cancer with different sensitizers
Elena G. Vakoulovskaya M.D., Victor V. Shental M.D., N. A. Abdoullin, Yury P. Kuvshinov, T. D. Tabolinovskaia, N. J. Edinak, Boris K. Poddubny, T. T. Kondratjeva, Gennadii A. Meerovich, Alexander A. Stratonnikov, Kirill G. Linkov, Valery V. Agafonov
Author Affiliations +
Abstract
This paper deals with the results of clinical trials for sulfated aluminum phthalocyanine (PHS) (Photosens, Russia) and Photogeme (PG) in Russia. The results of photodynamic therapy (PDT) of head and neck tumors (HNT), side effects and ways of their correction and prevention, as well as possibility to work out less toxic regimes of PDT with photosense, choice of laser and type of irradiation are discussed. PDT have been provided in 79 patients with different head and neck tumors. Efficacy of PDT depended on tumor size and its histological type. Undesirable changes in plasma content of antioxidants by means of high pressure liquid chromatography (HLPC) have been found in patients after PHS injection. Influence of short-term and long-term supplementation with beta-carotene and vitamin E on this parameters are discussed.
© (1997) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Elena G. Vakoulovskaya M.D., Victor V. Shental M.D., N. A. Abdoullin, Yury P. Kuvshinov, T. D. Tabolinovskaia, N. J. Edinak, Boris K. Poddubny, T. T. Kondratjeva, Gennadii A. Meerovich, Alexander A. Stratonnikov, Kirill G. Linkov, and Valery V. Agafonov "Photodynamic therapy of head and neck cancer with different sensitizers", Proc. SPIE 3191, Photochemotherapy: Photodynamic Therapy and Other Modalities III, (29 December 1997); https://doi.org/10.1117/12.297809
Lens.org Logo
CITATIONS
Cited by 2 scholarly publications.
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Photodynamic therapy

Head

Neck

Cancer

Tumors

Aluminum

Clinical trials

Back to Top